SCHEMBL1559932

SCHEMBL1559932

CCCCCCCCCCCCC(S)CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 11/20 0.62
FFAR1 O14842 3/20 0.50
FFAR4 Q5NUL3 2/20 0.50
PPARD Q03181 7/20 0.48
MAPT P10636 2/20 0.48
LCK P06239 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
KMT2A Q03164 2/20 0.47
PPARG P37231 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4779644 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL1573531 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL9654519 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL8359775 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL1557649 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL315421 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL15970061 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL1557632 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL16536984 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT
SCHEMBL2352562 1.00 GPR84 (0.62) GPR84FFAR1FFAR4PPARDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4510831-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2025-02-26 EP claimed
EP-3877572-B1 METALLIZATION INHIBITOR FOR RACKS EMPLOYED IN GALVANIC TREATMENTS MONTALDI S R L (IT) 2025-01-15 EP claimed
WO-2023202969-A1 ANTIBACTERIAL POLYMER AND PROCESS OF PREPARING THE SAME BASF SE (DE) 2023-10-26 WO claimed
US-20210372000-A1 METALLIZATION INHIBITOR FOR RACKS EMPLOYED IN GALVANIC TREATMENTS MONTALDI S.R.L. (IT) 2021-12-02 US claimed
EP-3877572-A1 METALLIZATION INHIBITOR FOR RACKS EMPLOYED IN GALVANIC TREATMENTS Montaldi S.r.l. (IT) 2021-09-15 EP claimed
EP-3691901-A1 UV CURABLE COMPOSITIONS WITH CONTROLLED MECHANICAL AND CHEMICAL PROPERTIES, METHODS, AND ARTICLES THEREFROM BASF SE (DE) 2020-08-12 EP claimed
WO-2019070587-A1 UV CURABLE COMPOSITIONS WITH CONTROLLED MECHANICAL AND CHEMICAL PROPERTIES, METHODS, AND ARTICLES THEREFROM BASF SE (DE) 2019-04-11 WO claimed
WO-2018207078-A1 STYRENE BUTADIENE LATEX BINDER FOR WATERPROOFING APPLICATIONS BASF SE (DE) 2018-11-15 WO claimed
EP-0973815-B1 RADIATION-CURABLE BINDER COMPOSITIONS HAVING HIGH ELONGATION AT BREAK AND TOUGHNESS AFTER CURE DSM IP ASSETS BV (NL) 2003-10-22 EP claimed
EP-0566801-B1 Organic solvent and water resistant, thermally, oxidatively and hydrolytically stable radiation-curable coatings for optical fibers, optical fibers coated therewith and processes for making same BORDEN INC (US) 1998-12-30 EP claimed
US-5587403-A ACRYLATED POLYETHERURETHANE COPOLYMER BORDEN, INC. (US) 1996-12-24 US claimed
US-5527835-A CURABLE ACRYLATED POLYETHERURETHANE WITH ACRYLATE MONOMERS, SILANE COUPLER AND PHOTOINITIATOR BORDEN, INC. (US) 1996-06-18 US claimed
EP-0566801-A2 Organic solvent and water resistant, thermally, oxidatively and hydrolytically stable radiation-curable coatings for optical fibers, optical fibers coated therewith and processes for making same BORDEN, INC. (US) 1993-10-27 EP claimed
US-5146531-A Acrylated polyurethane BORDEN, INC. (US) 1992-09-08 US claimed
EP-0109008-B1 STABILIZATION OF POLY-(ALKADIENE-1,3) BORG-WARNER CHEMICALS INC. (US) 1986-12-03 EP claimed
EP-0109008-A1 Stabilization of poly-(alkadiene-1,3) BORG-WARNER CHEMICALS INC. (US) 1984-05-23 EP claimed
US-20260146118-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL KURARAY CO., LTD. (JP) 2026-05-28 US disclosed
US-12612482-B2 Combination of crosslinkers to improve coating properties BASF SE (DE) 2026-04-28 US disclosed
US-4080364-A Stabilization of polyolefins against degradative deterioration as a result of exposure to light and air at elevated temperatures ARGUS CHEMICAL CORPORATION (US) 1978-03-21 US disclosed
US-4045404-A OXIDATIVE AND THERMAL STABILIZERS FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1977-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612482-B2 Combination of crosslinkers to improve coating properties BHMT2, FDFT1, MNAT1 GPR84 1669/4885FFAR1 305/4885FFAR4 656/4885
US-20260146118-A1 ACETALIZATION PRODUCT OF ETHYLENEVINYL ALCOHOL COPOLYMER, COMPOSITION CONTAINING SAID ACETALIZATION PRODUCT, AND BARRIER MATERIAL ADH1A, GK, ADH1C GPR84 3688/4885FFAR1 2703/4885FFAR4 1561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.